Reveald

Reveald sells continuous threat exposure management (CTEM): rather than shipping yet another scanner, it ingests findings from the vulnerability, identity, endpoint, and cloud tools an organization already owns (Tenable, Qualys, Rapid7, BloodHound, Entra ID, and others), then runs an attack-path engine over the combined data to show which exposures actually chain together into a viable route to a critical asset. The pitch is prioritization by real attack-path criticality rather than raw CVSS severity, which is the same problem attack-path and breach-and-attack-simulation vendors like XM Cyber and SafeBreach are also chasing.

The company’s current form is the product of a multi-year consolidation: Digitalware, an MSSP-turned-platform vendor founded in 2016, spun its Epiphany risk-hunting technology into a separate entity, Epiphany Systems, in 2021, then folded that back together under the Reveald name in 2022-2023 under CEO Dan Singer. Reveald is headquartered in New York and is backed by Secure Octane Investments; it acquired adversary-emulation vendor rThreat in 2024 to add validation capability to its exposure platform.

Because Reveald’s current corporate identity is only a few years old despite roots going back to 2016, independently verifiable market traction (named enterprise customers, analyst rankings, third-party breach-and-attack-simulation test results) is thinner in public sources than for more established CTEM competitors, even though the underlying attack-path technology has a longer development history.